Recothrom FDA Approval History
FDA Approved: Yes (First approved January 17, 2008)
Brand name: Recothrom
Generic name: Thrombin, topical (Recombinant)
Previous Name: rhThrombin
Company: ZymoGenetics, Inc.
Treatment for: Hemostasis During Surgery
Recothrom is a recombinant form of human thrombin indicated as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques is ineffective or impractical. Recothrom may be used in conjunction with an absorbable gelatin sponge, USP.
Development Timeline for Recothrom
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.